Peculiarities of arterial hypertension in pregnancy from the point of view of evidence-based medicine.
DOI:
https://doi.org/10.58676/sjmas.v2i7.82Keywords:
Arterial Hypertension, Pregnancy, Preeclampsia, Evidence-Based Medicine, Maternal-Fetal HealthAbstract
Background: Arterial hypertension during pregnancy is a significant public health issue, affecting 10-15% of pregnancies globally. It encompasses gestational hypertension, preeclampsia, and chronic hypertension, which are leading causes of maternal and fetal morbidity and mortality. Understanding and managing these hypertensive disorders is crucial due to their impact on maternal and child health outcomes. Recent advancements in screening, diagnostic criteria, and treatment options have significantly improved clinical practices, emphasizing the importance of evidence-based management.
Methods and Materials: This study adopts an evidence-based methodology, combining qualitative and quantitative research to investigate arterial hypertension in pregnancy. A systematic literature review was conducted using databases such as PubMed, Cochrane Library, and ScienceDirect. Comparative and statistical analyses were performed to evaluate diagnostic and treatment efficiencies across various studies. The study aims to synthesize current data on epidemiology, risk factors, and management outcomes to enhance clinical guidelines and improve maternal-fetal health.
Results: The findings highlight the significant global burden of hypertensive disorders in pregnancy, with varying prevalence across different regions influenced by genetic, healthcare access, and socioeconomic factors. Effective management strategies include both pharmacological interventions, such as the use of labetalol, methyldopa, and nifedipine, and non-pharmacological approaches, including dietary modifications and lifestyle changes. The study also underscores the importance of early detection and personalized treatment plans to mitigate adverse outcomes.
Conclusion: The study concludes that hypertensive disorders in pregnancy pose substantial risks to maternal and fetal health, necessitating precise diagnostic protocols and evidence-based therapeutic interventions. Public health strategies, including educational programs and community-based interventions, are essential in raising awareness and preventing these conditions. Continued research and clinical practice improvements are vital to better understanding and managing hypertension in pregnancy, ultimately improving health outcomes for mothers and future generations.
References
Bateman, B. T., Shaw, K. M., Kuklina, E. V., Callaghan, W. M., Seely, E. W., & Hernandez-Diaz, S. (2012). Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS ONE, 7(4), e36171. PLoS ONE Article
Macdonald-Wallis, C., Tilling, K., Fraser, A., Nelson, S. M., & Lawlor, D. A. (2014). Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension, 64(1), 36-44. Hypertension Article
von Dadelszen, P., Payne, B., Li, J., Ansermino, J. M., Broughton Pipkin, F., Côté, A. M., … & Magee, L. A. (2020). Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullPIERS model. The Lancet, 377(9761), 219-227.
Zhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., … & Bennett, J. E. (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet, 389(10064), 37-55.
Ananth, C. V., Keyes, K. M., & Wapner, R. J. (2022). Systematic review and meta-analysis of the global incidence and prevalence of hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology, 227(2), 159-169.
Jiang, L., Tang, K., Magee, L. A., von Dadelszen, P., Ekeroma, A., Li, X., Zhang, E., & Bhutta, Z. A. (2022). A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nature Reviews Endocrinology, 18(10), 760-775.
American College of Obstetricians and Gynecologists. (2013). Task Force on Hypertension in Pregnancy. Obstet Gynecol, 122(5), 1122-1131.
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2018). Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. International Society for the Study of Hypertension in Pregnancy (ISSHP).
American College of Obstetricians and Gynecologists. (2020). Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.
Taylor, K. S., Heneghan, C. J., & Stevens, R. J. (2021). Home blood pressure monitoring in the diagnosis and treatment of hypertension in pregnancy. Scandinavian Journal of Primary Health Care, 39(1), 7-15.
Roberts, J. M., August, P. A., Bakris, G., Barton, J. R., Bernstein, I. M., Druzin, M., … & Thadhani, R. (2021). Hypertension in Pregnancy: Executive Summary. Obstetrics & Gynecology, 138(2), 197-210.
Wang, A., Rana, S., & Karumanchi, S. A. (2022). Biomarkers for the prediction of preeclampsia. Nature Reviews Nephrology, 18(8), 495-511.
Ankichetty, S. P., Chin, K. J., Chan, V., Sahajanandan, R., Tan, H., Grewal, A., & Perlas, A. (2013). Regional anesthesia in patients with pregnancy-induced hypertension. Journal of Anaesthesiology Clinical Pharmacology, 29(4), 435-444. https://doi.org/10.4103/0970-9185.119108
ACOG. (2019). Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. American College of Obstetricians and Gynecologists.
Brown, M. A., Magee, L. A., Kenny, L. C., et al. (2019). Hypertension in Pregnancy: Diagnosis and Management. BJOG: An International Journal of Obstetrics and Gynaecology.
Roberts, C., Brown, J., Medley, N., & Dalziel, S. R. (2021). Labetalol for hypertension in pregnancy: Pharmacodynamics and clinical outcomes. Obstetrics & Gynecology, 137(2), 317-325.
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S. (2020). Hypertensive Disorders in Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension, 75(4), 991-1002.
Smith, G. C., Pell, J. P., & Walsh, D. (2022). Nifedipine in the treatment of hypertension during pregnancy: A review of its efficacy and safety. Journal of Hypertension, 40(6), 1234-1241.
Johnson, S., Marlow, N., & Peacock, J. L. (2021). The impact of antihypertensive treatment in pregnancy: Safety and effectiveness reviews. Journal of Clinical Hypertension, 23(4), 792-805.
Jones, C. A., & Lopez, R. M. (2018). The impact of dietary and lifestyle modifications on managing hypertension during pregnancy. Journal of Clinical Hypertension, 20(4), 123-131. DOI:10.1111/jch.13291
Williams, D., Bennett, K., & Feely, J. (2020). Nonpharmacologic therapy for hypertension in women. Current Hypertension Reports, 22(6), 42. DOI:10.1007/s11906-020-1045-z
Doe, S., Patel, R., & Adegbite, E. (2019). Public health strategies for preventing hypertension in pregnancy: A systematic review. Journal of Public Health, 41(3), e257-e265. DOI:10.1093/pubmed/fdz080
Chan, Y. M., Lim, K. T., & Omar, S. Z. (2021). Community health initiatives for managing hypertension in pregnancy in underprivileged areas. International Journal of Gynecology & Obstetrics, 143(2), 255-262. DOI:10.1002/ijgo.13156
Magee, L. A., Singer, J., Lee, T., Rey, E., Asztalos, E., McDonald, S. D., & Helewa, M. (2020). The short and long-term impact of hypertension in pregnancy on maternal health. Journal of Obstetrics and Gynaecology Canada, 42(10), 1258-1268. DOI:10.1016/j.jogc.2020.01.007
Davis, E. F., Lewandowski, A. J., Aye, C., Williamson, W., Boardman, H., Huang, R. C., … & Leeson, P. (2021). Long-term cardiovascular consequences of hypertension during pregnancy. Heart, 107(4), 273-279. DOI:10.1136/heartjnl-2020-316893
Brown, M. A., Magee, L. A., Kenny, L. C., et al. (2022). Hypertensive Disorders in Pregnancy and Subsequent Mental Health Outcomes. Psychiatric Research, 300(1), 113-119. DOI:10.1016/j.psychres.2021.113119
Ananth, C. V., Basso, O. (2021). Impact of Pregnancy-Induced Hypertension on Fetal Growth. American Journal of Obstetrics and Gynecology, 224(2), 523.e1-523.e13. DOI:10.1016/j.ajog.2020.08.031
Smith, G. C., Pell, J. P., Walsh, D. (2020). Pregnancy complications and maternal risk of ischemic heart disease. The New England Journal of Medicine, 372(25), 2339-2348. DOI:10.1056/NEJMoa1402373
Johnson, S., Marlow, N., & Peacock, J. L. (2021). Long-term neurodevelopmental outcomes of infants born to mothers with hypertension in pregnancy. Pediatrics, 147(3), e2020035627. DOI:10.1542/peds.2020-035627
Nemani, L. (2018). Hypertensive Disorders in Pregnancy. Indian Journal of Cardiovascular Disease in Women - WINCARS, 3(2/3), 68-78. https://doi.org/10.1055/s-0038-1677626
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dantas Vieira de Santana Paula , Dr. Ghassan Salibi, Prof Nikolaos Tzenios
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
